Drug · DIN 02433923
VALSARTAN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since September 1, 2017.
- Drug Identification Number (DIN)
- 02433923
- Company (DIN owner)
- Actavis Pharma CompanyToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Valsartan C09CA03
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VALSARTAN | 40 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 25, 2014: NOC 16357Abbreviated New Drug Submission (ANDS) · Additional product name
Other DINs named VALSARTAN
- DIN 02366940 · Marketed
- DIN 02366959 · Marketed
- DIN 02366967 · Marketed
- DIN 02366975 · Marketed
- DIN 02367726 · Marketed
- DIN 02367734 · Marketed
- DIN 02367742 · Marketed
- DIN 02367750 · Marketed
- DIN 02384523 · Marketed
- DIN 02384531 · Marketed
- DIN 02384558 · Marketed
- DIN 02384566 · Marketed
- DIN 02389320 · Cancelled Pre Market
- DIN 02389339 · Cancelled Pre Market
- DIN 02389347 · Cancelled Pre Market
- DIN 02433982 · Cancelled Pre Market
- DIN 02433990 · Cancelled Pre Market
- DIN 02434008 · Cancelled Pre Market